Vaxcyte saw the highest growth of 1.99% in patent filings in April and 0.99% in grants in June in Q2 2024. Compared to Q1 2024, Q2 2024 saw an increase in patent filings by 1.99% and no change in grants. GlobalData’s DataBook provides a comprehensive analysis of Vaxcyte‘s patent filings and grants. Buy the databook here.

Smarter leaders trust GlobalData

Vaxcyte has been focused on protecting inventions in United States(US) with three publications in Q2 2024

The United States(US) Patent Office dominates the patent filings and grants with nearly 50% filings and 100% grants. The United States(US), and South Korea(KR) patent Office are among the top ten patent offices where Vaxcyte is filings its patents. Among the top granted patent authorities, Vaxcyte has 100% of its grants in United States(US).

Roche and GSK could be the strongest competitors for Vaxcyte

Inflammation related patents lead Vaxcyte portfolio followed by periodontal disease, and periodontitis

Vaxcyte has highest number of patents in inflammation followed by periodontal disease, periodontitis, osteopenia, and pneumonia.

For comprehensive analysis of Vaxcyte's filings and grants, buy the databook here.

Data Insights

From

The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.

GlobalData

GlobalData patents database covers bibliographic from all 100+ patenting authorities. All patents are tagged to 18+ industries and 300+ sub-sectors based on technology classification, keywords, and associated companies. They are also tagged to various industries themes (100+) and technology domains (1800+) of focus.

Patents database further disambiguates assignee names (13m names) and associate corporate tree hierarchy in current/point in time ownerships (320k entities). GlobalData sources content directly from national patent offices on a weekly basis.